Terumo Corporation’s (TRUMY) wholly-owned subsidiary MicroVention, Inc. recently announced the publication of the Clinical Evaluation of WEB 17 Device in Intracranial Aneurysms (CLEVER) study results.
The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies 2-8 and over 200 peer-reviewed publications. Over the past 15 years, this revolutionary ...
MicroVention Inc., an Aliso Viejo-based startup medical device maker, has nabbed $10 million in an extension of its fourth round of venture funding. The new investment brings MicroVention’s total ...
Made of braided Nitinol wires, Sequent Medical's device is meant to treat wide-neck intracranial bifurcation aneurysms. Nancy Crotti Tokyo-based Terumo Corp. plans to buy Sequent Medical--a California ...
ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback